Randomized trial reveals clopidogrel enhances recovery from motor disorders in post-stroke patients, suggesting its potential in therapy.
This study investigates the auxiliary effect of clopidogrel on neurorehabilitation in patients with post-stroke movement disorders to evaluate its efficacy in rehabilitation treatment. A randomized controlled study is conducted, dividing patients into a conventional treatment group and a clopidogrel treatment group. The Fugl-Meyer score, Barthel Index, and NIHSS score are employed to assess and compare the patients’ motor function, daily activity ability, and neurological function before and after treatment. The scores for the Experimental Group exceed those of the Control Group for all measures, with p-values less than 0.05 or 0.01. These results indicate that the clopidogrel treatment group outperforms the conventional treatment group in stroke rehabilitation. This study examines clopidogrel’s auxiliary effect through a long-term experiment on the rehabilitation of patients with post-stroke movement disorders, offering new treatment ideas and methods for clinical practice.
No takes yet. Share an insight, caveat, or question.
A 2025 study studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: